Literature DB >> 24056879

The NR4A orphan nuclear receptors do not confer prednisolone resistance in pediatric acute lymphoblastic leukemia.

I M Ariës1, E S R van den Dungen1, R Pieters1, M L den Boer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24056879     DOI： 10.1038/leu.2013.275

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  14 in total

1.  Genetic variations in the glucocorticoid receptor gene are not related to glucocorticoid resistance in childhood acute lymphoblastic leukemia.

Authors:  Wim J E Tissing; Jules P P Meijerink; Monique L den Boer; Bas Brinkhof; Elisabeth F C van Rossum; Elisabeth R van Wering; Jan W Koper; Pieter Sonneveld; Rob Pieters
Journal:  Clin Cancer Res       Date:  2005-08-15       Impact factor: 12.531

2.  Protein-protein interactions and transcriptional antagonism between the subfamily of NGFI-B/Nur77 orphan nuclear receptors and glucocorticoid receptor.

Authors:  Christine Martens; Steve Bilodeau; Mario Maira; Yves Gauthier; Jacques Drouin
Journal:  Mol Endocrinol       Date:  2004-12-09

Review 3.  Minireview: Nuclear hormone receptor 4A signaling: implications for metabolic disease.

Authors:  Michael A Pearen; George E O Muscat
Journal:  Mol Endocrinol       Date:  2010-04-14

4.  Functional redundancy of the Nur77 and Nor-1 orphan steroid receptors in T-cell apoptosis.

Authors:  L E Cheng; F K Chan; D Cado; A Winoto
Journal:  EMBO J       Date:  1997-04-15       Impact factor: 11.598

5.  Three related brain nuclear receptors, NGFI-B, Nurr1, and NOR-1, as transcriptional activators.

Authors:  R F Paulsen; K Granas; H Johnsen; V Rolseth; S Sterri
Journal:  J Mol Neurosci       Date:  1995       Impact factor: 3.444

6.  Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.

Authors:  Amy Holleman; Meyling H Cheok; Monique L den Boer; Wenjian Yang; Anjo J P Veerman; Karin M Kazemier; Deqing Pei; Cheng Cheng; Ching-Hon Pui; Mary V Relling; Gritta E Janka-Schaub; Rob Pieters; William E Evans
Journal:  N Engl J Med       Date:  2004-08-05       Impact factor: 91.245

7.  In vitro cellular drug resistance in children with relapsed/refractory acute lymphoblastic leukemia.

Authors:  E Klumper; R Pieters; A J Veerman; D R Huismans; A H Loonen; K Hählen; G J Kaspers; E R van Wering; R Hartmann; G Henze
Journal:  Blood       Date:  1995-11-15       Impact factor: 22.113

8.  Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86.

Authors:  A Reiter; M Schrappe; W D Ludwig; W Hiddemann; S Sauter; G Henze; M Zimmermann; F Lampert; W Havers; D Niethammer
Journal:  Blood       Date:  1994-11-01       Impact factor: 22.113

9.  Abrogation of nuclear receptors Nr4a3 and Nr4a1 leads to development of acute myeloid leukemia.

Authors:  Shannon E Mullican; Shuo Zhang; Marina Konopleva; Vivian Ruvolo; Michael Andreeff; Jeffrey Milbrandt; Orla M Conneely
Journal:  Nat Med       Date:  2007-05-21       Impact factor: 53.440

10.  Prednisolone resistance in childhood acute lymphoblastic leukemia: vitro-vivo correlations and cross-resistance to other drugs.

Authors:  G J Kaspers; R Pieters; C H Van Zantwijk; E R Van Wering; A Van Der Does-Van Den Berg; A J Veerman
Journal:  Blood       Date:  1998-07-01       Impact factor: 22.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.